Claims
- 1. A compound of the formula: or a pharmaceutically acceptable salt thereof.
- 2. The compound of claim 1 wherein the compound is represented by the formula: or a pharmaceutically acceptable salt thereof.
- 3. The compound of claim 2 wherein the compound is represented by the formula:
- 4. The compound of claim 2 wherein the compound is represented by the formula:
- 5. The compound of claim 2 wherein the compound is represented by the formula:
- 6. The compound of claim 2 wherein the compound is represented by the formula:
- 7. A compound of the formula: or a pharmaceutically acceptable salt thereof.
- 8. The compound of claim 7 wherein the compound is represented by the formula:
- 9. The compound of claim 7 wherein the compound is represented by the formula:
- 10. The compound of claim 7 wherein the compound is represented by the formula:
- 11. The compound of claim 7 wherein the compound is represented by the formula:
- 12. A compound of the formula: or a pharmaceutically acceptable salt thereof.
- 13. The compound of claim 12 wherein the compound is represented by the formula: or a pharmaceutically acceptable salt thereof.
- 14. The compound of claim 12 wherein the compound is represented by the formula: or a pharmaceutically acceptable salt thereof.
- 15. The compound of claim 12 wherein the compound is represented by the formula: or a pharmaceutically acceptable salt thereof.
- 16. The compound of claim 12 wherein the compound is represented by the formula: or a pharmaceutically acceptable salt thereof.
- 17. A pharmaceutical composition comprising a compound of claim 12 and a pharmaceutically acceptable carrier.
- 18. A compound or salt selected from the group consisting of: wherein Z is benzyloxycarbonyl, Boc is tert-butoxycabonyl, and Bn is benzyl.
- 19. The compound of claim 18 wherein said compound is
- 20. The compound of claim 18 wherein said compound is
- 21. The compound of claim 18 wherein said compound is
- 22. The compound of claim 18 wherein said compound is
- 23. The salt of claim 18 wherein said salt is
- 24. The compound of claim 18 wherein said compound is
- 25. The salt of claim 18 wherein said salt is
- 26. A compound of the formula: or a pharmaceutically acceptable salt thereof.
- 27. A compound of the formula: or a pharmaceutically acceptable salt thereof.
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Application Serial No. 60/222,179, filed Aug. 1, 2000.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
5854234 |
Hansen et al. |
Dec 1998 |
A |
5994391 |
Lee et al. |
Nov 1999 |
A |
Foreign Referenced Citations (5)
Number |
Date |
Country |
0521471 |
Jan 1993 |
EP |
WO9511231 |
Apr 1995 |
WO |
WO9633175 |
Oct 1996 |
WO |
WO9706802 |
Feb 1997 |
WO |
WO9964426 |
Dec 1999 |
WO |
Non-Patent Literature Citations (2)
Entry |
S Moncada and EA Higgs, FASEB Journal, 9: 1319-1330 1995. |
WO 99/64426 (Abstract). |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/222179 |
Aug 2000 |
US |